Astrazeneca Pharma India standalone net profit rises 184.76% in the March 2021 quarter

Sales rise 7.88% to Rs 210.26 crore

Net profit of Astrazeneca Pharma India rose 184.76% to Rs 27.28 crore in the quarter ended March 2021 as against Rs 9.58 crore during the previous quarter ended March 2020. Sales rose 7.88% to Rs 210.26 crore in the quarter ended March 2021 as against Rs 194.90 crore during the previous quarter ended March 2020.

For the full year,net profit rose 29.19% to Rs 93.30 crore in the year ended March 2021 as against Rs 72.22 crore during the previous year ended March 2020. Sales declined 2.19% to Rs 813.56 crore in the year ended March 2021 as against Rs 831.81 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales210.26194.90 8 813.56831.81 -2 OPM %19.227.59 -16.6514.51 - PBDT42.6817.89 139 147.22132.55 11 PBT36.8413.35 176 127.09113.97 12 NP27.289.58 185 93.3072.22 29

Powered by Capital Market - Live News